Pelago provides specialty substance use care with personalized, virtual-first support for tobacco, alcohol, opioid, cannabis, and stimulant use. Their approach includes digital tools, live counseling, medication-assisted treatment (MAT), and same-day access nationwide. Pelago focuses on stigma-free care built around personal goals and offers physician-led care teams, complex condition management, access to inpatient treatment facilities, personalized tech and support such as cognitive behavioral therapy (CBT), remote monitoring with at-home devices, and a members’ hub for MAT called PelagoRX. The company is led by addiction scientists and a multidisciplinary team with 15 peer-reviewed publications demonstrating impact on engagement, clinical improvement, and medical savings.